Three-dimensional cultures (or “organoids”) derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These “organoid” cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
“This is the first time that a collection of cancer organoids, or a living biobank, has been derived from patient tumors,” says senior study author Mathew Garnett, a geneticist at the Wellcome Trust Sanger Institute. “We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments.”
To study the causes of cancer and develop new cancer treatments, many laboratories use experimental model systems such as cells grown from patient tumors. However, currently available cell lines have been derived under suboptimal conditions and therefore fail to reflect important features of tumor cells. As a result, it has been challenging to predict the drug sensitivity of individual patients based on their unique spectrum of genetic mutations.
In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish. In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present, and their self-renewal properties. Given the advantages of organoids, Garnett and Hans Clevers of the Hubrecht Institute set out to test whether these cultures could potentially bridge the gap between cancer genetics and patient outcomes.
In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures. The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations. These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer.
To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs. Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs. In validation of the approach, the researchers identified previously reported associations between specific mutations and resistance to particular drugs. The organoids also revealed a novel gene-drug association, indicating that the subset of cancer patients with RNF43 mutations would strongly benefit from a drug that inhibits a protein called porcupine. “At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment,” Garnett says.
The Latest on: Organoids
via Google News
The Latest on: Organoids
- Researchers create three-dimensional organoid models of human forebrainon January 24, 2020 at 6:42 am
In their paper published in the journal Science, the group describes growing the organoids and their uses. The organoids are spherical structures that self-organize into models of different parts of ...
- “Organoids” Reveal How Human Forebrain Developson January 24, 2020 at 5:07 am
“But everything beyond the second trimester [of pregnancy] and soon after birth is poorly understood.” Enter the invention of brain “organoids”: cells grown in 3-D clusters in the lab and designed to ...
- Lab-Grown Venom Glands Could Open Door To Better, More Modern Way To Treat Snakebiteson January 24, 2020 at 4:51 am
In other public health news: depression, genetic testing, uterine fibroids, deadly genetic mutations, and more. Stat: Labs Study Mini Brains And Lungs. Next Up: Snake Venom Gland Organoids The ...
- Snake's venom glands grown in lab for first timeon January 23, 2020 at 1:26 pm
Jan. 23 (UPI) --Scientists have successfully grown organoids composed of snake venom gland cells in the lab. The mini glands successfully produced the active toxins that compose snake venom. The ...
- An Ethical Future for Brain Organoids Takes Shapeon January 23, 2020 at 9:22 am
Collaborations in progress between ethicists and biologists seek to head off challenges raised by lab-grown “organoids” as they become increasingly similar to human brain tissue. Part of the brain’s ...
- Snake cells grown in the lab produce venom we could use as medicineon January 23, 2020 at 8:55 am
Snake glands have for the first time been grown in the lab as tiny balls of cells called organoids that become filled with venom. It might mean the end of “milking” snakes for their venom by hand to ...
- Venom-producing snake organoids developed in the labon January 23, 2020 at 8:34 am
Researchers from the group of Hans Clevers at the Hubrecht Institute (KNAW), in an international collaboration, have developed a method to grow snake venom gland cells as organoids. These lab-grown ...
- Snake stem cells used to create venom-producing organoidson January 23, 2020 at 8:17 am
Organoids have become an important tool for studying many disease processes and testing potential drugs. Now, they are being used in a surprising and unexpected way: for the production of snake venom.
- How to Make Snake Venom Without Any Snakeson January 23, 2020 at 8:16 am
“That is what I asked my Ph.D. students,” he said. A decade ago, Clevers realized that stem cells from a mouse’s gut, when bathed in the right chemicals, could produce organoids—miniature versions of ...
- There’s a Perfectly Good Reason to Mass-Produce Snake Venomon January 23, 2020 at 8:05 am
Lab-grown glands can now produce realistic cocktails of toxins, which could help address one of the world’s biggest and most neglected health crises.
via Bing News